A patient with COVID-19 and bleeding complications due to neurofibromatosis type 1 during VV-ECMO: A case report.
Keiichiro ShimoyamaKazunari AzumaJun OdaPublished in: Medicine (2022)
We propose non-anticoagulation treatment strategy for the management of VV-ECMO in patients with NF1. Especially under the COVID-19 pandemic, more careful consideration should be given to the indications for VV-ECMO in patients with NF1.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- signaling pathway
- respiratory failure
- lps induced
- atrial fibrillation
- coronavirus disease
- sars cov
- pi k akt
- oxidative stress
- nuclear factor
- mechanical ventilation
- case report
- venous thromboembolism
- risk factors
- inflammatory response
- intensive care unit
- immune response
- combination therapy